GoHealth (NASDAQ:GOCO) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(0.95) by 10.53 percent. The company reported quarterly sales of $185.600 million which beat the analyst consensus estimate of $180.154 million by 3.02 percent. This is a 1.33 percent increase over sales of $183.158 million the same period last year.
GoHealth Q1 2024 Adj EPS $(0.85) Beats $(0.95) Estimate, Sales $185.600M Beat $180.154M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.